Table of Contents
List of Tables
List of Figures
InspireMD Inc Company Overview
InspireMD Inc Company Snapshot
InspireMD Inc Pipeline Products and Ongoing Clinical Trials Overview
InspireMD Inc – Pipeline Analysis Overview
InspireMD Inc – Key Facts
InspireMD Inc – Major Products and Services
InspireMD Inc Pipeline Products by Development Stage
InspireMD Inc Ongoing Clinical Trials by Trial Status
InspireMD Inc Pipeline Products Overview
CGuard Embolic Prevention System
CGuard Embolic Prevention System Product Overview
CGuard Embolic Prevention System Clinical Trial
MGuard Drug Eluting Stent
MGuard Drug Eluting Stent Product Overview
Next Gen CGuard – 5F
Next Gen CGuard – 5F Product Overview
NGuard
NGuard Product Overview
PVGuard Peripheral
PVGuard Peripheral Product Overview
RGuard Renal
RGuard Renal Product Overview
InspireMD Inc – Key Competitors
InspireMD Inc – Key Employees
InspireMD Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
InspireMD Inc, Recent Developments
Mar 10, 2020: InspireMD announces fourth quarter and year-end 2019 financial results
Jan 29, 2020: InspireMD announces successful live clinical case transmissions featuring CGuard EPS at the Leipzig Interventional Course (LINC) 2020
Jan 27, 2020: InspireMD’s CGuard Embolic Prevention System to be prominently featured in live case transmission at LINC, 28th to the 31st January 2020, in Leipzig, Germany
Jan 06, 2020: InspireMD announces strong preliminary fourth quarter 2019 revenue and reports inducement award under NYSE American Company Guide §711(a)
Dec 10, 2019: InspireMD announces planned leadership transition
Dec 10, 2019: InspireMD announces planned leadership transition
Nov 26, 2019: InspireMD reports updated positive CGuard EPS data presented at VEITH 2019
Nov 12, 2019: InspireMD announces third quarter 2019 financial results
Sep 09, 2019: InspireMD provides business update
Aug 06, 2019: InspireMD announces second quarter 2019 financial results
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
InspireMD Inc Pipeline Products and Ongoing Clinical Trials Overview
InspireMD Inc Pipeline Products by Equipment Type
InspireMD Inc Pipeline Products by Indication
InspireMD Inc Ongoing Clinical Trials by Trial Status
InspireMD Inc, Key Facts
InspireMD Inc, Major Products and Services
InspireMD Inc Number of Pipeline Products by Development Stage
InspireMD Inc Pipeline Products Summary by Development Stage
InspireMD Inc Ongoing Clinical Trials by Trial Status
InspireMD Inc Ongoing Clinical Trials Summary
CGuard Embolic Prevention System - Product Status
CGuard Embolic Prevention System - Product Description
CGuard Embolic Prevention System - A Multicenter Italian Registry of Real World CAS with C-Guard Mesh Covered Stent: The IRONGUARD 2 Study
CGuard Embolic Prevention System - A Pivotal Study of the CGuard Carotid Stent System CARENET-III for Prevention of Stroke in Patients in the United States.
CGuard Embolic Prevention System - Carotid Artery Revascularization Using TransCarotid flow Reversal Cerebral Protection And CGUARD MicroNET-covered Embolic Prevention Stent System to Reduce Strokes in Patients with Symptoms or Signs of Cerebral Ischemia: TOP-GUARD Study
CGuard Embolic Prevention System - Independent Randomized Trial in Carotid Artery Revascularization Comparing the Stent (Acculink) Versus the Mesh Covered Stent (CGuard): The SIBERIA Trial
CGuard Embolic Prevention System - Long-term Outcomes of MicroNet-covered Stent Routine Use for Stroke Prevention in Symptomatic and Increased-risk Asymptomatic Carotid Stenosis Patients Requiring Revascularization by Neurovascular Team Decision: PARADIGM-EXTEND
CGuard Embolic Prevention System - OPTIMAl Endovascular Exclusion of High-risk Carotid Plaque Using the CGuard Stent in Patients with Symptoms or Signs of Carotid Stenosis-related Brain Injury: IVUS Controlled Investigator Initiated Multcentric Multi-specialty Study
CGuard Embolic Prevention System - Prospective Evaluation of All-comer Percutaneous Carotid Revascularization In Symptomatic and Increased-risk Asymptomatic Carotid Artery Stenosis
CGuard Embolic Prevention System - Prospective Observational Study of CGuard MicroNet Covered Stent System Use as a Flow Diverter in the Endovascular Exclusion of Carotid Artery Aneurysms. (CGuard Divert-and-HEAL C-HEAL)
CGuard Embolic Prevention System - Prospective Observational Study of Procedures with MicroNet Covered Stent Use to Treat Increased Risk Lesions in Arterial Locations Beyond the Carotid Bifurcation - FLOW-Guard Study
MGuard Drug Eluting Stent - Product Status
MGuard Drug Eluting Stent - Product Description
Next Gen CGuard - 5F - Product Status
Next Gen CGuard - 5F - Product Description
NGuard - Product Status
NGuard - Product Description
PVGuard Peripheral - Product Status
PVGuard Peripheral - Product Description
RGuard Renal - Product Status
RGuard Renal - Product Description
InspireMD Inc, Key Employees
InspireMD Inc, Other Locations
InspireMD Inc, Subsidiaries
Glossary